Increased plasma 8-isoprostane levels in hypertensive subjects: The Tsurugaya project

被引:53
作者
Hozawa, A
Ebihara, S
Ohmori, K
Kuriyama, S
Ugajin, T
Koizumi, Y
Suzuki, Y
Matsui, T
Arai, H
Tsubono, Y
Sasaki, H
Tsuji, I
机构
[1] Tohoku Univ, Grad Sch Med & Pharmaceut Sci, Dept Publ Hlth, Sendai, Miyagi 9808575, Japan
[2] Tohoku Univ, Grad Sch Med & Pharmaceut Sci, Dept Forens Med, Sendai, Miyagi 9808575, Japan
[3] Tohoku Univ, Grad Sch Med & Pharmaceut Sci, Dept Geriatr & Resp Med, Sendai, Miyagi 9808575, Japan
[4] Tohoku Univ, Grad Sch Med & Pharmaceut Sci, Dept Geriatr & Complementary Med, Sendai, Miyagi 9808575, Japan
[5] Tohoku Univ, Grad Sch Med & Pharmaceut Sci, Dept Clin Pharmacol & Therapeut, Sendai, Miyagi 9808575, Japan
[6] Tohoku Univ, Grad Sch Med & Pharmaceut Sci, Dept Psychiat, Sendai, Miyagi 9808575, Japan
关键词
hypertension; oxidative stress; isoprostanes; home blood pressure measurement; elderly;
D O I
10.1291/hypres.27.557
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
To examine the relationship between 8-isoprostane and blood pressure, we measured plasma 8-isoprostane concentration and home blood pressure levels in an elderly Japanese population. Our study population comprised 569 subjects aged 70 years and over who were not receiving antihypertensive medication. On the basis of their blood pressure values, the participants were classified into three groups: normotensive (home blood pressure < 135/85 mmHg), hypertensive (home blood pressure 135/85-160/90 mmHg), and severely hypertensive (home blood pressure greater than or equal to160/90 mmHg). The mean plasma 8-isoprostane level in the severely hypertensive group (21.1 +/- 5.2 pg/ml) was significantly higher than that in the normotensive (20.2 +/- 4.9 pg/ml) or hypertensive (19.7 +/- 5.1 pg/ml) group, and this result was unchanged when we adjusted for possible confounding factors such as age, sex, use of vitamin A, C or E supplements, smoking status, drinking status, body mass index, use of non-steroidal anti-inflammatory drugs, history of diabetes, hypercholesterolemia, home heart rate and serum creatinine level. Thus, the level of plasma 8-isoprostane appears to be elevated in older subjects with severe hypertension.
引用
收藏
页码:557 / 561
页数:5
相关论文
共 20 条
[1]  
Association for the Advancement of Medical Instrumentation (AAMI), 1987, AM NAT STAND EL AUT
[2]   Measurement of urinary 8-epi-prostaglandin F-2 alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction gas chromatography mass spectrometry. Basal levels in smokers and nonsmokers [J].
Bachi, A ;
Zuccato, E ;
Baraldi, M ;
Fanelli, R ;
Chiabrando, C .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (04) :619-624
[3]   Device for the self-measurement of blood pressure that can monitor blood pressure during sleep [J].
Chonan, K ;
Kikuya, M ;
Araki, T ;
Fujiwara, T ;
Suzuki, M ;
Michimata, M ;
Hashimoto, J ;
Ohkubo, T ;
Hozawa, A ;
Yamamoto, N ;
Miyawaki, Y ;
Matsubara, M ;
Imai, Y .
BLOOD PRESSURE MONITORING, 2001, 6 (04) :203-205
[4]  
Clarke R, 2003, J INTERN MED, V254, P67, DOI 10.1046/j.1365-2796.2003.01154.x
[5]   Elevated plasma levels of F2α isoprostane in cystic fibrosis [J].
Collins, CE ;
Quaggiotto, P ;
Wood, L ;
O'Loughlin, EV ;
Henry, RL ;
Garg, ML .
LIPIDS, 1999, 34 (06) :551-556
[6]  
Davì G, 1999, CIRCULATION, V99, P224
[7]   Dietary supplementation with aged garlic extract reduces plasma and urine concentrations of 8-iso-prostaglandin F2α in smoking and nonsmoking men and women [J].
Dillon, SA ;
Lowe, GM ;
Billington, D ;
Rahman, K .
JOURNAL OF NUTRITION, 2002, 132 (02) :168-171
[8]   Low-dose angiotensin II increases free isoprostane levels in plasma [J].
Haas, JA ;
Krier, JD ;
Bolterman, RJ ;
Juncos, LA ;
Romero, JC .
HYPERTENSION, 1999, 34 (04) :983-986
[9]   Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial [J].
Huang, HY ;
Appel, LJ ;
Croft, KD ;
Miller, ER ;
Mori, TA ;
Puddey, IB .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (03) :549-555
[10]   Usefulness of home blood pressure measurements in assessing the effect of treatment in a single-blind placebo-controlled open trial [J].
Imai, Y ;
Ohkubo, T ;
Hozawa, A ;
Tsuji, I ;
Matsubara, M ;
Araki, T ;
Chonan, K ;
Kikuya, M ;
Satoh, H ;
Hisamichi, S ;
Nagai, K .
JOURNAL OF HYPERTENSION, 2001, 19 (02) :179-185